INTRODUCTION
Viral equine influenza is one of the major diseases to affect horses worldwide [6, 16, 35, 36] and requires a great deal of veterinary attention [31] . The disease is caused by the equine influenza type A virus, an RNA virus belonging to the Orthomyxoviridae family. The viral RNA consists of eight independent segments that allow easy recombination, which gives rise to new viral subtypes [12, 27] . In horses there are two subtypes of influenza A virus. H3N8 (A/equine-2, first recognized in Miami in 1963), which is the most commonly isolated, and subtype H7N7 (A/equine-1, first described in Prague in 1956), which is more rarely isolated [13, 18, 25] . In Chile, both subtypes, H7N7 (A/equi-1/Santiago/77, [4] ) and H3N8 (A/equi-2/Santiago/85, [3] ) have been isolated. Equine influenza has severe consequences; sick animals remain incapacitated for up to four weeks. In addition they require a training period to return to competitive levels. Pregnant mares may abort or suffer fetal reabsorption during the first months of pregnancy.
In Chile, the disease has emerged in both summer and winter months at irregular intervals of four to eight years. As a consequence of the lack of preventive measures or of poorly-planned vaccination programs, assorted outbreaks have caused heavy damage to livestock throughout the country.
One of the evasion mechanisms of the viruses is the antigenic drift, which allows evasion from the host's immune system. As a consequence, each subtype carries significant antigenic changes that allow the virus to persist for several years.
Because of the high morbidity and economic losses associated with outbreaks of equine influenza, intense vaccination programs are employed in an effort to control infection. However, the vaccines currently available are based on inactivated whole virus and only offer a limited short-term protection. Outbreaks of the disease have occurred in vaccinated horses, although they have presented milder symptoms as compared with non-vaccinated animals. Vaccine failure is primarily attributed to viral antigenic changes [34] , and new approaches to vaccination are therefore needed.
As a first step toward the development of vaccines for the Chilean and South American markets we are isolating viral genes from the Chilean subtypes. This report describes the isolation and sequence features of the hemagglutinin (HA), neuraminidase (NA) and nucleoprotein (NP) coding regions of both subtypes. The purpose of this study is to understand the bases of the antigenic changes of the virus from this region in order to better design an effective vaccine.
MATERIALS AND METHODS

Virus culture and isolation of viral RNA
Viruses from isolates of A/equi-1/Santiago/ 77 (Sa77) and A/equi-2/Santiago/85 (Sa85) were cultured in embryonated 10 or 11-dayold chicken eggs as described elsewhere [14] . The isolates we used were maintained through a process involving multiple viral transfers. This is particularly relevant in the case of isolate Sa85, whose RNA exhibited sequence differences compared with the original sequence reported by Kawaoka et al. [11] . The isolate from which the HA gene was sequenced in this paper is named Santiago 85b (Sa85b). Viral RNA was extracted from the allantoic fluid using Trizol LS (Invitrogen) according to Chomczynski [5] as described previously [30] . This RNA was used to amplify and isolate relevant genes by RT-PCR using random hexanucleotides as primers according to Sambrook and Russell [23] .
Amplification and cloning
Genes were amplified by PCR using primers designed after the conserved regions of the desired sequences (Table I) and cloned into vector pCR2.1 (Invitrogen). Recombinant plasmids were selected after analysis by PCR and digestion with endonucleases EcoRl, Sall and Xbal. Plasmid DNA was prepared as described previously [15] .
Sequencing
Relevant genes were sequenced according to Sanger et al. [24] ATGGCGTCTCAAGGCACCAAA  TTAACTGTCAAACTCCTCAGC  NA7  AAGCAGGGTAATTTTGAAATG  TTACGAAAAGTATTTAATTTG  NA8  ATGAATCCAAATCAAAAGATA  CGTAAATTACATCTTATCGAT  HA7  ATGAACACTCAAATTCTAATATTAGCCAC  TCATATACAAATAGTGCACCGCATGTTTC  HA3 ATGAAGACAACCATTATTTTGATACTACTG TCAAATGCAAATGTTGCATCTGATGTTGCC accession numbers AY383752 and AY383753 (Sa77 and Sa85, respectively). Neuraminidase sequences have accession numbers AY383757 (Sa77) and AY383754 (Sa85); hemagglutinin sequences have accession numbers AY383756 (Sa77) and AY383755 (Sa85b).
Bioinformatic analysis
Sequence analyses were performed using the Blast N and Clustal X1.8 programs [29] . Phylogenetic trees were constructed using Saitou and Nei's Neighbor-joining method [22] and displayed employing the Treeview drawing program [19] . The statistical validity of this analysis is supported by the bootstrap analysis performed using 1,000 bootstrapped data sets.
RESULTS
Sequence analysis of genes coding for nucleoprotein. Alignment and comparison with other isolates of equine influenza virus
Nucleoprotein is the primary protein of the nucleocapsid and is coded by the fifth viral RNA segment. It is a type-specific antigen used to classify the equine influenza virus into groups A, B, and C. [2] . The fact that this nucleoprotein has not been found again indicates that it may be an extinct lineage.
A high degree of correlation between amino acid changes and the year of the isolate may be appreciated with the exception of Jilin 1989 (Ji89). Although it is similar to the avian isolates [7] , it should also be remembered that it is separated from Pr56 by thirty years. Isolates from the same decade are quite comparable as it can be seen from the data for 1986 (North American) and those from 1985 and 1977 (Chilean).
The resulting phylogenetic tree is shown in Figure 1 . The tree has four branches; one corresponds to Pr56, the second to Ji89, the third to Miami 1963 (Mi63) and the fourth to the most recent isolates. The nucleoprotein from the isolate Pr56, which is the most primitive and closest to the avian virus ancestor [7] , shows the fewest similarities. Isolate Ji89, although more recent, has been classified as similar to the avian [8] . The remaining isolates show a high degree of homology. From this data we estimate a mutation rate of 0.33 events per year.
Sequence analysis of genes coding for neuraminidase. Alignments and comparison with other isolates of the equine influenza virus.
Coded by the sixth segment of viral RNA, this enzyme splits the α-keto bond that joins a terminal sialic acid and the next sugar residue, thereby allowing the release of the viral progeny from infected cells. There are 9 subtypes of this protein identified in nature. They all have two structural regions, a stalk, and a head. Subtypes N7 and N8 have been found in viruses affecting horses. All N8 proteins studied have 470 amino acids in which the first 8 are highly conserved, followed by a region rich in hydrophobic amino acids considered to be the transmembrane domain of the enzyme. The stalk is made up of the following 51 amino acids, and the head region begins with Cys90. The catalytic site of the enzyme is found in this last region.
We compared the N7 neuraminidase coding region of isolate Sa77 with two sequences available in the database, all having 1,410 base pairs. Additionally, the neuraminidase nucleotide sequence from the Chilean isolate Sa85 of subtype N8, obtained in this work was compared with nine published sequences of different lengths, but we only used the codogenic region corresponding to 1,416 base pairs. The homology between them ranges from 89-99% (results not shown).
We also compared the cysteine residues and glycosylation sites of NA of subtype N8 with the nine published sequences. All of the N8 proteins analyzed have 17 highlyconserved cysteine residues; one is in the stalk region and the others in the head section. Cysteine residues from the head section are highly conserved in other neuraminidase subtypes such as N1, N2, N5, N7 and N9 [21] . All sequences analyzed have 7 putative N-glycosylation sites, with the exception of isolate Mi63, Sao Paulo 1969 (SP69), and Ji89, which have only 6, and Alaska 1991 (Ak91), which has 8. Conserved sites in all isolates are located in residues 46, 54, 144, 293, and 400. The stalk region has only one cysteine residue and at least 3 glycosylation sites, while Sa85 has 4 reputed sites. Homology ranges from 92-99% in amino acid sequence, in which the stalk region (amino acids 39 to 89) is the most divergent (88-98%). Figure 2 shows the phylogenetic tree drawn from the amino acid sequences deduced from the nucleotide sequences of all isolates. The data suggests that two subtypes of neuraminidase can be singled out. For N7, 21 of the 470 amino acids in the sequence of isolate Pr56 are different 
Sequence analysis of genes coding for hemagglutinin. Alignments and comparison with other isolates of equine influenza virus
This membrane glycoprotein is responsible for the adsorption of the virus into the host cell. It is the main antigen to which neutralizing antibodies are directed and its antigenic variation is the major cause of influenza epidemics. The hemagglutinin is coded by the fourth viral RNA segment. The protein has a signal peptide of 16 amino acids and two polypeptides (HA1 & HA2) joined by disulfide bridges where HA1 includes the amino terminal end, and HA2 has the carboxyl end [6] . This last polypeptide includes a hydrophobic region that allows the anchoring of the hemagglutinin to the viral membrane.
Different subtypes of hemagglutinin have been described, although only subtypes H3 and H7 are found in infected horses.
Characterization of hemagglutinin subtype H7.
Subtype H7 was the first isolated in horses in 1956 in Prague, and its latest report was in 1978 [32] . The nucleotide sequence from isolate Sa77 showed that the hemagglutinin coding region has 1,713 base pairs which code a polypeptide of 570 amino acids. In this study, 10 sequences obtained from Genbank database are compared with isolate Sa77. Results are shown in Table  III . The 11 isolates show a remarkable homology in their nucleotide sequences (96%-99%), corresponding to a conserved amino acid sequence (95%-99%). Figure 3 shows the phylogenetic tree obtained from the amino acid sequences of H7 from different isolates. The results show two well-defined groups, the earlier European isolates Pr56 and Cambridge 1963 (Ca63) and the others, reflecting a distant relation between them. Isolates from 1964 on show a high homology (~98%). We can also distinguish 3 groups. One is the North American lineage group constituted by the two Detroit 1964 isolates (De64, CDe64), the second is the European lineage, and a third is the South American lineage which comprises isolates Sao Paulo 1976 (SP76) and Sa77. The amino acid sequence of this hemagglutinin shows a high degree of conservation in the first 9 amino acids; the tenth amino acid of the isolate Sa77 is invariable with respect to isolates from the 1950's and 1960's and isolates from the 1970's. There are 5 antigenic sites defined for H3 from human isolates [37] that can be extrapolated to H7, where there are amino acid substitutions in positions 164, 168, 169, 198, 202 and 208 of the antigenic site B (located in the most exposed region of the protein) (Table IV) . Mutations present in residues 164, 169 and 198 correspond to differences among earlier isolates (1958) (1959) (1960) (1961) (1962) (1963) , in contrast to the rest of the isolates. In position 208, a mutation is present in the last isolates of this subtype, Sa77 and Switzerland 1972 (Sw72). In antigenic site D there are mutations in residues 182, 183, 211, 220, 223 and 253; isolate Sa77 has three of them. In antigenic site E there are mutations in positions 67 and 96 only in the earlier isolates (Pr56, Ca63).
In this study we also analyzed the glycosylation sites of hemagglutinin subtype H7, which are involved in the immune evasion mechanism of the virus. In polypeptide HA1 we have two highlyconserved putative sites in positions 46 There are 5 highly conserved putative Nglycosylation sites located in residues 37, 53, 78, 180, and 300 of HA1. The 26 sequences from the literature show 6 possible glycosylation sites in HA1 with the exception of the Uruguay 1963 isolate (Ur63), which has 5. In HA2 isolates there is a single highly-conserved site in position 498, which is the only N-glycosylation site in this polypeptide.
In HA1, there are 9 cysteine residues with the exception of Mi63 that has 8; they form 4 intra-chain disulfide bridges and one of them links HA1 to HA2. In HA2 there are 8 highly-conserved cysteine residues.
The amino acid variation in relevant antigenic sites of hemagglutinin is shown in Table V 
old isolates, into arginine in isolates from 1976 to 1988, or into lysine in isolates of 1989 (with the exception of Ji89). In the antigenic site E (amino acids 59-63 and 94-99), residue 63 shows a mutation in which isoleucine is substituted for threonine, characterizing isolates from 1976 on.
Comparing the amino acid sequences of HA from isolate Sa85b (sequenced in this work) to isolate Sa85 [11] , 7 differences are found. Two of them correspond to antigenic sites E and D (residues 95 and 260 respectively). Five are unique; they are not found in 25 of the 26 isolates listed in the literature. Of these five, two (residues 108 and 238) appear in both, proving that it is unique for isolates Sa85 and Sa85b. Another, a change in residues 88 and 237 (Sa85) reported by Kawaoka [11] , was not confirmed in our sequence. A third difference, found in residue 225 between isolates Sa85 and Sa85b, was observed in other isolates after repeated cultures in embryonated eggs [9] .
Analyzing the phylogenetic tree of the 27 sequences (Fig. 4) 
DISCUSSION
In agreement with previous reports [1, 28] , the sequence analysis of the two equine influenza strains isolated in Chile demonstrates that the nucleoprotein is a good antigen to be considered in a vaccine formulation as it is highly-conserved in influenza type A viruses and exclusive of viruses that infect horses. This gene undergoes mutations at a very low rate and generates cellular and humoral immunity in DNA vaccines that are not affected by maternal antibodies [20] . The phylogenetic trees show that the first virus isolates (Pr56 and Mi63) have a great similitude with avian isolates. This fact would indicate, as Gorman et al. have suggested [7] , that the equine virus originated from the avian virus. Furthermore, isolate Ji89 was classified as "aviar-like" and is very close to the first isolates, as we noted in all of the proteins analyzed here. Mutation rates of neuraminidase and hemagglutinin are similar, suggesting that both membrane proteins are under comparable selective pressures from the host.
Although strain H7N7 has not been isolated for more than 20 years, circulating antibodies against it have been reported [16] . It was decided that H7N7 would be maintained as a vaccine-strain, although it might be advisable to incorporate a strain derived from the post 1964 group, which could be more effective than the currentlyused Pr56 isolate. Carbohydrate chains may modulate the biological activity of glycoproteins influencing the virulence of the isolate; it can be used as a blocking mechanism to antibody linking. Isolate Sa77 has the highest number of glycosilation sites.
With respect to the HA of subtype H3, in agreement with results in the literature [26] most amino acid substitutions in Sa85 are found in the protein's globular region. This globular region, whose three-dimensional structure is known [36] , contains all the known antigenic sites.
Comparing the entire sequence of HA of isolate Sa85b with all sequences from the 1990's available in the Genbank (Fig. 5) , we found that it belongs to the same branch of Kentucky 1990 (Ke90) and Kentucky 1992 (Ke92) isolates and is less similar to the South American isolates Argentina 1993 (Ar93), Argentina 1994 (Ar94), La Plata 1993 (LP93) and Kentucky 91 (Ke91). They have a lower mutation rate compared with the rest of the strains, of 0.27 amino acids per year or 0.8 x 10 -3 amino acids per site per year [10] . Selecting polypeptide HA1, where relevant antigenic sites are found, site C in residues 51-54, site D in residues 240-245 and E, in residues 43-47 have no differences compared with American or European isolates. Antigenic site A of isolate Sa85b has one amino acid that differs from the American isolates and one from the European ones. In site B there are 4 differences in the amino acid sequence as compared with American isolates. Site C has 3 differences with the European isolates but none with the American ones. Site D has only one difference with isolates of the 1990's and one with isolates Ar95 and Ar96. We therefore conclude that isolates Sa77 and Sa85 are good vaccine candidates, as they appear to preserve the most relevant antigenic determinants.
